WASHINGTON, D.C. — October 19, 2026. President Donald Trump signed an executive order Monday establishing a new federal initiative dedicated to women’s health, with First Lady Melania Trump taking a leading role in promoting the plan. The announcement promises expanded medical research, faster diagnoses and improved treatment options, but it also raises a significant question: how much new funding will be available to turn those commitments into results?
Signed during a White House Rose Garden ceremony, the order directs the National Institutes of Health (NIH) to establish a Women’s Health Division within 90 days and creates a White House Women’s Health Task Force. The initiative will focus on medical conditions that disproportionately or uniquely affect women, while seeking to improve healthcare across every stage of life.
A NEW NIH DIVISION TO ADDRESS WOMEN’S HEALTH RESEARCH GAPS
The newly ordered division will work alongside the NIH’s existing Office of Research on Women’s Health, which has operated since 1990. Rather than replacing that office, the administration wants the new structure to expand coordination across federal agencies and accelerate the translation of scientific discoveries into practical medical treatments.
Research priorities include cardiovascular disease, cancer, autoimmune disorders, chronic pain, endometriosis, infertility, uterine fibroids, menopause, osteoporosis, Alzheimer’s disease and maternal health. The executive order also calls for stronger participation of women and girls in clinical trials and greater attention to biological differences that can influence disease and treatment outcomes.
MELANIA TRUMP PUSHES ARTIFICIAL INTELLIGENCE AND AFFORDABLE CARE
Melania Trump presented five priorities for the initiative, emphasizing research funding for conditions affecting women, the use of advanced artificial intelligence, faster development of treatments, improved affordability and more open conversations about women’s health.
The first lady has advocated using emerging technology to identify medical discoveries more efficiently and reduce delays between laboratory research and patient care. The administration says its approach will support medical innovation while maintaining scientific and safety standards.
SUSIE WILES AND ROBERT F. KENNEDY JR. TO LEAD WHITE HOUSE TASK FORCE
White House Chief of Staff Susie Wiles and Health and Human Services Secretary Robert F. Kennedy Jr. will co-chair the new task force. Its responsibilities include coordinating federal health agencies, identifying gaps in medical research and encouraging healthcare policies that improve prevention, diagnosis and treatment.
The group will bring together officials from the NIH, Food and Drug Administration, Centers for Disease Control and Prevention, and other federal departments. It may also consult outside experts, universities, technology companies and healthcare organizations to identify research opportunities and potential improvements to patient care.
NEW ORDER REVOKES BIDEN-ERA WOMEN’S HEALTH DIRECTIVES
The announcement also marks a change in federal policy. Trump’s executive order revokes two actions initiated under former President Joe Biden: a November 2023 presidential memorandum establishing a White House women’s health research initiative and a March 2024 executive order intended to advance research and innovation in the field.
The previous initiative, championed by former First Lady Jill Biden, was associated with nearly $1 billion in federal research funding commitments, according to the Biden administration. The Trump White House argues that its new approach will improve coordination and broaden the application of research through advanced technologies. However, the October 19 order does not specify additional research funding, leaving questions about the initiative’s financial resources and how its objectives will be implemented.
FUNDING QUESTIONS EMERGE AMID PREVIOUS NIH RESEARCH CUTS
The initiative arrives as the administration faces criticism over earlier reductions in federal scientific research funding and changes to healthcare programs. Some affected grants involved research related to women’s health, prompting questions about how the new priorities will align with previous spending decisions. The administration maintains that it is working to improve research quality, efficiency and long-term health outcomes.
For researchers and patients, the next major test will be implementation. Federal officials must establish the new NIH division within 90 days, while the task force begins coordinating its work. Whether the initiative produces additional funding, faster medical breakthroughs or measurable improvements in access to care remains to be determined.
